10 Years of Molecular Autism
2020 marked a decade since Molecular Autism was established to accelerate and integrate research into neurodevelopmental conditions.
Read our retrospective collection of the most impactful publications from the last ten years here.
Announcing the launch of In Review
In partnership with Research Square, Molecular Autism is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Read more about the full range of benefits of In Review and how to opt in, or see the In Review platform for yourself here.
Articles
-
-
Disruption of grin2B, an ASD-associated gene, produces social deficits in zebrafish
-
Salivary testosterone in male and female youth with and without autism spectrum disorder: considerations of development, sex, and diagnosis
-
Oxytocin impacts top-down and bottom-up social perception in adolescents with ASD: a MEG study of neural connectivity
-
Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice
-
Hans Asperger, National Socialism, and “race hygiene” in Nazi-era Vienna
The Correction to this article has been published in Molecular Autism 2021 12:45
-
Savant syndrome has a distinct psychological profile in autism
-
Quantifying compensatory strategies in adults with and without diagnosed autism
-
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
-
DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes
Collections
Editors-in-Chief
Simon Baron-Cohen, University of Cambridge, UK
Joseph Buxbaum, Icahn School of Medicine at Mount Sinai, New York
Aims and scope
Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.
We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Joseph Buxbaum, co-Editor-in-Chief
Joseph Buxbaum is a molecular geneticist and neuroscientist, Director of the Seaver Autism Center for Research and Treatment, and Professor at the Icahn School of Medicine at Mount Sinai. Dr Buxbaum is the founder and co-lead investigator of the Autism Sequencing Consortium, an international collaboration to discover genes for autism. He has also been elected to the prestigious National Academy of Medicine (NAM), in recognition of his important contributions to uncovering the genetic and molecular basis of autism.
Simon Baron-Cohen, co-Editor-in-Chief
Simon Baron-Cohen is Professor of Developmental Psychopathology at the University of Cambridge and Fellow at Trinity College, Cambridge. He is also Director of the Autism Research Centre (ARC) in Cambridge and Director of CLASS (Cambridge Lifespan Asperger Syndrome Service), a clinic for adults with suspected AS.
Follow
Annual Journal Metrics
-
Citation Impact
6.476 - 2-year Impact Factor (2021)
8.016 - 5-year Impact Factor (2021)
1.916 - Source Normalized Impact per Paper (SNIP)
2.638 - SCImago Journal Rank (SJR)Speed
29 days to first decision for all manuscripts (Median)
53 days to first decision for reviewed manuscripts only (Median)Usage
902,898 downloads (2021)
2,760 Altmetric mentions (2021)